drugset / Trial / NCT01450306

Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics

NCT01450306

Completed 20 enrolled Hartford Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the present study is to determine whether people receiving d-cycloserine and exposure therapy show different brain reactions to symptom provocation compared to people receiving placebo and exposure therapy.

Timeline

Start
2010-07
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule 50 mg Oral

Indications